Welcome to CDC Stacks | Impact of recent innovations in the use of mass cytometry in support of drug development - 36266 | CDC Public Access
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
Impact of recent innovations in the use of mass cytometry in support of drug development
Filetype[PDF - 329.87 KB]


Details:
  • Pubmed ID:
    26092491
  • Pubmed Central ID:
    PMC4668584
  • Funding:
    R21 OH010438/OH/NIOSH CDC HHS/United States
    R21 OH010494/OH/NIOSH CDC HHS/United States
  • Document Type:
  • Collection(s):
  • Description:
    Cytometry by time-of-flight (CyTOF) is a novel technology for the real-time analysis of single cells. CyTOF is a significant advance in fields including immunology, hematology, and oncology. It resolves multiple metal-conjugated probes per cell with minimal signal overlap, which maximizes the information obtained from each individual sample. CyTOF provides the ability to phenotypically and functionally profile cells from normal and diseased states. Single cell technologies enable researchers to measure the effects of a drug at the single cell level and better understand its mechanism of action. Here, we discuss novel instruments for the analysis of individual biological cells, the impact of recent innovations in support of drug development, and the important roles of CyTOF in drug profiling.